Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. MeiraGTx Holdings plc
  6. News
  7. Summary
    MGTX   KYG596651029

MEIRAGTX HOLDINGS PLC

(MGTX)
  Report
Delayed Nasdaq  -  03:52 2022-08-17 pm EDT
9.800 USD   -6.84%
08/12Chardan Research Trims MeiraGTx Holdings Price Target to $46 From $47, Maintains Buy Rating
MT
08/11MeiraGTx's Q2 Net Loss Per Diluted Share Widens; Expects Sufficient Capital Through Q4 2024
MT
08/11MEIRAGTX HOLDINGS PLC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MeiraGTx Sees Positive Data From Phase 1/2 Trial of Botaretigene Sparoparvovec for X-Linked Retinitis Pigmentosa Patients

06/28/2022 | 08:12am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON 0.14% 167.84 Delayed Quote.-2.05%
MEIRAGTX HOLDINGS PLC -6.84% 9.8 Delayed Quote.-55.69%
All news about MEIRAGTX HOLDINGS PLC
08/12Chardan Research Trims MeiraGTx Holdings Price Target to $46 From $47, Maintains Buy Ra..
MT
08/11MeiraGTx's Q2 Net Loss Per Diluted Share Widens; Expects Sufficient Capital Through Q4 ..
MT
08/11MEIRAGTX HOLDINGS PLC Management's Discussion and Analysis of Financial Condition and ..
AQ
08/11MEIRAGTX : Reports Second Quarter 2022 Financial and Operational Results - Form 8-K
PU
08/11MeiraGTx Reports Second Quarter 2022 Financial and Operational Results
GL
08/11MeiraGTx Holdings plc Reports Earnings Results for the Second Quarter and Six Months En..
CI
08/10NORTH AMERICAN MORNING BRIEFING : Caution -2-
DJ
08/04MEIRAGTX : Announces Financing Agreement with Perceptive Advisors for Up to $100 Million S..
PU
08/04MEIRAGTX HOLDINGS PLC : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
08/03MeiraGTx Says it Gets $100 Million Term Loan From Perceptive Advisors; MeiraGTx Shares ..
MT
More news
Analyst Recommendations on MEIRAGTX HOLDINGS PLC
More recommendations
Financials (USD)
Sales 2022 43,9 M - -
Net income 2022 -103 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,49x
Yield 2022 -
Capitalization 470 M 470 M -
Capi. / Sales 2022 10,7x
Capi. / Sales 2023 9,48x
Nbr of Employees 333
Free-Float 71,9%
Chart MEIRAGTX HOLDINGS PLC
Duration : Period :
MeiraGTx Holdings plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEIRAGTX HOLDINGS PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 10,52 $
Average target price 31,14 $
Spread / Average Target 196%
EPS Revisions
Managers and Directors
Alexandria Forbes President, Chief Executive Officer & Director
Richard Giroux Chief Operating & Financial Officer
Keith Reginald Harris Director
Robert K. Zeldin Chief Medical Officer
Ellen Hukkelhoven Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MEIRAGTX HOLDINGS PLC-55.69%470
GILEAD SCIENCES, INC.-8.65%82 985
VERTEX PHARMACEUTICALS37.98%78 356
REGENERON PHARMACEUTICALS, INC.2.72%68 773
WUXI APPTEC CO., LTD.-23.26%40 492
BIONTECH SE-37.79%39 486